{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:32:19Z","timestamp":1790893939901,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T00:00:00Z","timestamp":1308268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10549-011-1624-x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T19:07:50Z","timestamp":1308337670000},"page":"565-573","source":"Crossref","is-referenced-by-count":97,"title":["Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer"],"prefix":"10.1007","volume":"132","author":[{"given":"Cecilia L.","family":"Speyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassia","family":"Mekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,17]]},"reference":[{"issue":"5","key":"1624_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.canep.2009.10.003","volume":"33","author":"SS Coughlin","year":"2009","unstructured":"Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33(5):315\u2013318","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"1624_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71\u201396","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1624_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12282-009-0111-2","volume":"16","author":"J Kurebayashi","year":"2009","unstructured":"Kurebayashi J (2009) Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics. Breast Cancer 16(4):275\u2013280","journal-title":"Breast Cancer"},{"issue":"1","key":"1624_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.03.016","volume":"256","author":"RB Riggins","year":"2007","unstructured":"Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH (2007) Pathways to tamoxifen resistance. Cancer Lett 256(1):1\u201324","journal-title":"Cancer Lett"},{"issue":"2","key":"1624_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","volume":"11","author":"D Gajria","year":"2011","unstructured":"Gajria D, Chandarlapaty S (2011) HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies. Expert Rev Anticancer Ther 11(2):263\u2013275","journal-title":"Expert Rev Anticancer Ther"},{"issue":"10","key":"1624_CR6","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1074\/jbc.273.10.5615","volume":"273","author":"A Francesconi","year":"1998","unstructured":"Francesconi A, Duvoisin RM (1998) Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J Biol Chem 273(10):5615\u20135624","journal-title":"J Biol Chem"},{"issue":"7","key":"1624_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0165-6147(00)01678-3","volume":"22","author":"MJ Marinissen","year":"2001","unstructured":"Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22(7):368\u2013376","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1624_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","volume":"34","author":"JP Pin","year":"1995","unstructured":"Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34(1):1\u201326","journal-title":"Neuropharmacology"},{"issue":"1","key":"1624_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MN:29:1:01","volume":"29","author":"JQ Wang","year":"2004","unstructured":"Wang JQ, Tang Q, Parelkar NK, Liu Z, Samdani S, Choe ES, Yang L, Mao L (2004) Glutamate signaling to Ras-MAPK in striatal neurons: mechanisms for inducible gene expression and plasticity. Mol Neurobiol 29(1):1\u201314","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1624_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semcdb.2003.12.020","volume":"15","author":"C Waters","year":"2004","unstructured":"Waters C, Pyne S, Pyne NJ (2004) The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol 15(3):309\u2013323","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"1624_CR11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00004647-200109000-00001","volume":"21","author":"V Bruno","year":"2001","unstructured":"Bruno V, Battaglia G, Copani A, D\u2019 Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21(9):1013\u20131033","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1624_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2165\/00003495-199651010-00004","volume":"51","author":"BW Festoff","year":"1996","unstructured":"Festoff BW (1996) Amyotrophic lateral sclerosis: current and future treatment strategies. Drugs 51(1):28\u201344","journal-title":"Drugs"},{"issue":"1","key":"1624_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/089771502753460213","volume":"19","author":"CD Mills","year":"2002","unstructured":"Mills CD, Johnson KM, Hulsebosch CE (2002) Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain. J Neurotrauma 19(1):23\u201342","journal-title":"J Neurotrauma"},{"issue":"2","key":"1624_CR14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1523\/JNEUROSCI.5019-07.2008","volume":"28","author":"JA Ronesi","year":"2008","unstructured":"Ronesi JA, Huber KM (2008) Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J Neurosci 28(2):543\u2013547","journal-title":"J Neurosci"},{"issue":"5","key":"1624_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1126\/stke.15pe6","volume":"1","author":"JA Ronesi","year":"2008","unstructured":"Ronesi JA, Huber KM (2008) Metabotropic glutamate receptors and fragile\u00a0\u00d7\u00a0mental retardation protein: partners in translational regulation at the synapse. Sci Signal 1(5):6","journal-title":"Sci Signal"},{"issue":"1\u20132","key":"1624_CR16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainres.2004.07.074","volume":"1024","author":"T Endoh","year":"2004","unstructured":"Endoh T (2004) Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius. Brain Res 1024(1\u20132):212\u2013224","journal-title":"Brain Res"},{"issue":"3","key":"1624_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","volume":"8","author":"A Carnero","year":"2008","unstructured":"Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF (2008) The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8(3):187\u2013198","journal-title":"Curr Cancer Drug Targets"},{"issue":"10","key":"1624_CR18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nm762","volume":"8","author":"G Viglietto","year":"2002","unstructured":"Viglietto G, Motti ML, Bruni P, Melillo RM, D\u2019Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M (2002) Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB\/Akt-mediated phosphorylation in breast cancer. Nat Med 8(10):1136\u20131144","journal-title":"Nat Med"},{"issue":"1","key":"1624_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng1148","volume":"34","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, Zhu H, Robbins C, Makalowska I, Shin SS, Marin Y, Roberts KG, Yudt LM, Chen A, Cheng J, Incao A, Pinkett HW, Graham CL, Dunn K, Crespo-Carbone SM, Mackason KR, Ryan KB, Sinsimer D, Goydos J, Reuhl KR, Eckhaus M, Meltzer PS, Pavan WJ, Trent JM, Chen S (2003) Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 34(1):108\u2013112","journal-title":"Nat Genet"},{"issue":"4","key":"1624_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2008.04.021","volume":"55","author":"SS Shin","year":"2008","unstructured":"Shin SS, Martino JJ, Chen S (2008) Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology 55(4):396\u2013402","journal-title":"Neuropharmacology"},{"issue":"3","key":"1624_CR21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1755-148X.2008.00452.x","volume":"21","author":"SS Shin","year":"2008","unstructured":"Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, Chen S (2008) Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res 21(3):368\u2013378","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"1624_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14660820310002601","volume":"4","author":"RG Miller","year":"2003","unstructured":"Miller RG, Mitchell JD, Lyon M, Moore DH (2003) Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 4(3):191\u2013206","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"5","key":"1624_CR23","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","volume":"67","author":"J Namkoong","year":"2007","unstructured":"Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS, Chen S (2007) Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67(5):2298\u20132305","journal-title":"Cancer Res"},{"issue":"8","key":"1624_CR24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cellsig.2005.10.012","volume":"18","author":"YE Marin","year":"2006","unstructured":"Marin YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, Oka M, Chen S (2006) Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1\/2 via PKCepsilon. Cell Signal 18(8):1279\u20131286","journal-title":"Cell Signal"},{"issue":"1","key":"1624_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1755-148X.2009.00648.x","volume":"23","author":"SS Shin","year":"2010","unstructured":"Shin SS, Wall BA, Goydos JS, Chen S (2010) AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res 23(1):103\u2013111","journal-title":"Pigment Cell Melanoma Res"},{"issue":"57","key":"1624_CR26","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1038\/onc.2008.329","volume":"27","author":"Y Ohtani","year":"2008","unstructured":"Ohtani Y, Harada T, Funasaka Y, Nakao K, Takahara C, Abdel-Daim M, Sakai N, Saito N, Nishigori C, Aiba A (2008) Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene 27(57):7162\u20137170","journal-title":"Oncogene"},{"issue":"11","key":"1624_CR27","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-08-3303","volume":"15","author":"D Yip","year":"2009","unstructured":"Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, Yudd A, Kempf J, Shih WJ, Chen S, Goydos JS (2009) A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 15(11):3896\u20133902","journal-title":"Clin Cancer Res"},{"issue":"28","key":"1624_CR28","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","volume":"24","author":"L Hou","year":"2004","unstructured":"Hou L, Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24(28):6352\u20136361","journal-title":"J Neurosci"},{"issue":"4","key":"1624_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuropharm.2008.06.019","volume":"55","author":"T Scartabelli","year":"2008","unstructured":"Scartabelli T, Gerace E, Landucci E, Moroni F, Pellegrini-Giampietro DE (2008) Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy? Neuropharmacology 55(4):509\u2013516","journal-title":"Neuropharmacology"},{"issue":"4","key":"1624_CR30","first-page":"204","volume":"11","author":"RD Zhang","year":"1991","unstructured":"Zhang RD, Fidler IJ, Price JE (1991) Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 11(4):204\u2013215","journal-title":"Invasion Metastasis"},{"issue":"5","key":"1624_CR31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/mol.59.5.965","volume":"59","author":"FY Carroll","year":"2001","unstructured":"Carroll FY, Stolle A, Beart PM, Voerste A, Brabet I, Mauler F, Joly C, Antonicek H, Bockaert J, Muller T, Pin JP, Prezeau L (2001) BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol 59(5):965\u2013973","journal-title":"Mol Pharmacol"},{"issue":"4","key":"1624_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","volume":"7","author":"KM Noh","year":"2000","unstructured":"Noh KM, Hwang JY, Shin HC, Koh JY (2000) A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 7(4):375\u2013383","journal-title":"Neurobiol Dis"},{"issue":"7","key":"1624_CR33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-10-1276","volume":"17","author":"AJ Khan","year":"2011","unstructured":"Khan AJ, Wall B, Ahlawat S, Green C, Schiff D, Mehnert JM, Goydos JS, Chen S, Haffty BG (2011) Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo. Clin Cancer Res 17(7):1807\u20131814","journal-title":"Clin Cancer Res"},{"issue":"14","key":"1624_CR34","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-04-1408","volume":"65","author":"C Kuperwasser","year":"2005","unstructured":"Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA, Rosenblatt M (2005) A mouse model of human breast cancer metastasis to human bone. Cancer Res 65(14):6130\u20136138","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1624-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1624-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T21:08:52Z","timestamp":1560287332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,17]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1624-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,17]]}}}